Tina Bhutani, MD: Improvement in Patient-reported Symptoms and Satisfaction with Tildrakizumab in a Real-world Study in Patients with Moderate-to-severe Plaque Psoriasis
Tina Bhutani, MD, discusses a new article published in the October 2024 issue of JCAD that describes patient-reported symptoms and treatment satisfaction in patients with moderate-to-severe plaque psoriasis treated with tildrakizumab 100mg over 64 weeks. Read full article here Reference:
Emmy Graber, MD: ARM Yourself with Knowledge Alopecia and Atopic Dermatitis Meeting
Dr. Graber discusses an upcoming CME-accredited virtual meeting focusing on alopecia and atopic dermatitis. Register for the meeting here.
Alice Gottlieb, MD, PhD: Diagnostic Delay of Psoriatic Arthritis of More Than Six Months Contributes to Poor Patient-Reported Outcome Measures in Depression, Social Ability, and Disease Impact
Alice Gottlieb, MD, PhD, discusses a new article published in the October 2024 issue of JCAD that sought to correlate the time lag between psoriatic arthritis symptom onset and diagnosis to the likelihood and severity of depression, social impairment, and disease impact on quality of life. Read full article here Reference:
Emmy Graber, MD: ARM Yourself with Knowledge Acne and Rosacea Meeting
Dr. Graber discusses an upcoming CME-accredited virtual meeting focusing on acne and rosacea. Access Acne and Rosacea meeting here.
James Song, MD, FAAD: Checking in on Long-term Safety Data on JAK Inhibitors for Atopic Dermatitis
Dr. Song discusses the latest safety data on topical and oral JAK inhibitors for patients with atopic dermatitis.